Noveris flags heavy potential dilution and control shift from debt-conversion deals

Mydecine Innovations Group ( (TSE:NVRS) ) has shared an update.

Noveris Health Sciences Inc. has provided supplemental disclosure on two previously issued convertible debentures used to settle significant outstanding debts owed to its CEO, David Joshua Bartch, and to related party Pioneer Garage Limited. The Bartch debenture totals about CAD $1.31 million in unpaid management fees, while the Pioneer debenture, roughly CAD $7.88 million, consolidates prior debenture balances, invoices paid on Noveris’ behalf and consideration tied to the MindLeap settlement.

Both debentures mature in one year and are convertible after a four-month-plus-one-day hold period at a price linked to the 20-day volume-weighted average share price, subject to Canadian Securities Exchange minimums. Using an illustrative conversion price of $0.185, full conversion could expand the share count from 1.24 million to about 50.9 million shares, with Pioneer potentially owning over 80% and becoming a control person, and the CEO holding just under 14%.

The company warned that full conversion may cause it to fall short of the CSE’s continued listing requirements for public float and distribution, risking a review that could lead to suspension or delisting if compliance cannot be maintained. Noveris framed the disclosure as a transparency measure on potential dilution and control implications, noting that actual conversion terms and future capital structure changes will determine the ultimate impact on governance and minority shareholders.

More about Mydecine Innovations Group

Noveris Health Sciences Inc., listed on the CSE, FSE and OTC markets, operates in the health sciences sector. The company appears focused on financial restructuring and debt management arrangements involving key executives and related parties, reflecting efforts to stabilize its capital structure and address legacy obligations.

Average Trading Volume: 3,067

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$216.1K

For an in-depth examination of NVRS stock, go to TipRanks’ Overview page.